Search alternatives:
decrease release » decreases disease (Expand search), decrease renal (Expand search), protease release (Expand search)
decrease drugs » disease drugs (Expand search), release drugs (Expand search), decrease treg (Expand search)
drugs decrease » drugs increases (Expand search), drugs release (Expand search)
decrease rate » decreased rate (Expand search), decreases rate (Expand search), decrease at (Expand search)
rate decrease » rats decreases (Expand search), rate increase (Expand search), to decrease (Expand search)
release after » relapse after (Expand search), decrease after (Expand search), disease after (Expand search)
decrease not » decrease of (Expand search), decrease at (Expand search), decrease akt (Expand search)
not decrease » to decrease (Expand search), not increase (Expand search), and decrease (Expand search)
decrease release » decreases disease (Expand search), decrease renal (Expand search), protease release (Expand search)
decrease drugs » disease drugs (Expand search), release drugs (Expand search), decrease treg (Expand search)
drugs decrease » drugs increases (Expand search), drugs release (Expand search)
decrease rate » decreased rate (Expand search), decreases rate (Expand search), decrease at (Expand search)
rate decrease » rats decreases (Expand search), rate increase (Expand search), to decrease (Expand search)
release after » relapse after (Expand search), decrease after (Expand search), disease after (Expand search)
decrease not » decrease of (Expand search), decrease at (Expand search), decrease akt (Expand search)
not decrease » to decrease (Expand search), not increase (Expand search), and decrease (Expand search)
1
2
3
“... (MW) PCL after 1 month in vivo. The high MW PCL showed non-cumulative release rates above the therapeutic...”
Access document
Access document
4
“... de demonstrar possÃvel efeito vasorelaxante in vitro e anti-hipertensivo in vivo. Ratos Wistar machos (200-250...”
Access document
Access document
Doctoral thesis
5
“...: 1mM 4-aminopirimidine [Emax=26.48±10.50 %], 10 μM glibenclamide [Emax=27.97±3.7%], was not significantly modified after...”
Access document
Access document
Master thesis
6
“..., there is an increase in the release of DA from the ventral tegmental area (VTA) to structures such...”
Access document
Access document
Master thesis
7
“...Ruthenium coordinated nitric oxide donors which do not release cyanide can be less toxic models...”
Access document
Access document
Doctoral thesis
8
9
10
“... de citocinas inflamatórias liberadas pelo segmento lombar da medula espinhal de ratos submetidos ao modelo...”
Access document
Access document
Master thesis
11
12
“... do miocárdio em ratos (Olivares et al ., 2007), sendo que esta mesma condição ocorreu em cardiopatias clínicas...”
Access document
Access document
Doctoral thesis
13
14
“.... Discussion: The remifentanil rate did not differ between the groups, even between the times for GCAR. However...”
Access document
Access document
Article
15
16
“... pelo doador de NO [Ru(phen)2(TU)NO] (PF6) 3+ (FOR 911B) em aorta isolada de rato. No presente estudo...”
Access document
Access document
Master thesis
17
“..., essas diferentes condições clínicas possuem uma relação bidirecional. Diversos estudos em ratos, nos últimos anos...”
Access document
Access document
Doctoral thesis
18
19
“... a ingestão de salina hipertônica em condições basais ou após a depleção corporal de sódio em ratos machos...”
Access document
Access document
Doctoral thesis
20
“...) intensidades sobre marcadores inflamatórios em ratas wistar com hepatotoxicidade induzida por CP. Para tanto...”
Access document
Access document
Master thesis